HCP1 Activators
The chemical class termed HCP1 Activators comprises a diverse group of compounds that potentially influence the activity of HCP1 (SLC46A1), a transporter crucial for intestinal folate absorption. These chemicals, rather than directly activating HCP1, play a significant role in modulating the body's folate metabolism and homeostasis, thereby indirectly affecting HCP1 activity.
Key representatives of this class are various folate metabolism inhibitors, including methotrexate, trimethoprim, and pyrimethamine. These agents, by inhibiting dihydrofolate reductase, create a cellular state of relative folate deficiency. This deficiency, in turn, can trigger compensatory mechanisms within the body to upregulate HCP1, enhancing folate absorption from the gut. This indirect activation underscores the body's capacity to adapt to changes in nutrient availability and metabolism. Additionally, compounds like phenobarbital, phenytoin, and carbamazepine, which are known to interfere with folate absorption or metabolism, can also lead to a similar compensatory increase in HCP1 activity. This increase is part of the body's effort to maintain folate homeostasis, particularly in situations where folate metabolism is disrupted.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Pyrimethamine | 58-14-0 | sc-208190 sc-208190A sc-208190B | 1 g 5 g 25 g | $80.00 $238.00 $825.00 | 5 | |
Inhibits dihydrofolate reductase in protozoa. Its use in humans might create a compensatory increase in HCP1 activity due to altered folate metabolism. | ||||||
Sulfamethoxazole | 723-46-6 | sc-208405 sc-208405A sc-208405B sc-208405C | 10 g 25 g 50 g 100 g | $37.00 $55.00 $69.00 $109.00 | 5 | |
Works synergistically with trimethoprim to inhibit bacterial folate synthesis. Its effect on human folate metabolism might indirectly upregulate HCP1. | ||||||
5,5-Diphenyl Hydantoin | 57-41-0 | sc-210385 | 5 g | $70.00 | ||
An anticonvulsant known to interfere with folate absorption, potentially increasing the demand for folate and indirectly upregulating HCP1. | ||||||
Carbamazepine | 298-46-4 | sc-202518 sc-202518A | 1 g 5 g | $33.00 $71.00 | 5 | |
Similar to phenytoin, can affect folate metabolism and might lead to increased HCP1 activity to compensate for reduced folate levels. | ||||||
Folic Acid | 59-30-3 | sc-204758 | 10 g | $73.00 | 2 | |
High doses of folic acid might downregulate HCP1 due to reduced need for folate absorption, but cessation could lead to a rebound increase in HCP1 activity. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Used is known to interfere with folate metabolism, potentially increasing HCP1 activity. | ||||||
Aminopterin | 54-62-6 | sc-202461 | 50 mg | $102.00 | 1 | |
Its inhibition of folate metabolism could lead to increased demand for folate, potentially enhancing HCP1 activity. | ||||||